ASO Article Series: Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy
Release Date: 09/22/2025
SurgOnc Today®
In this episode of SurgOnc Today, SSO Breast Disease Site Working Group members Drs. David Anderson, Fred Dirbas, and Suzanne Klimberg dive into management of male breast cancer. The speakers discuss unique considerations for this population as well as the similarities and overlap when treating female breast cancer.
info_outlineSurgOnc Today®
In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Mecker G. Möller crucial questions regarding colorectal peritoneal metastasis (CRC-PM) management, particularly concerning the optimal applications of HIPEC in clinical practice, as reported in the article, "Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases—Should It Be Offered?”
info_outlineSurgOnc Today®
In this episode of SurgOnc Today, Jonathan Baines, MD, Donald Warne, MD, and Lori Arviso Alvord, MD discuss advocacy and mentoring of Native American and URM Trainees.
info_outlineSurgOnc Today®
In this episode of SurgOnc Today, Mark Knab, Charles Vining, and Kelvin Allenson discuss how the anatomic location of duodenal adenocarcinoma—from the first to the fourth portion—fundamentally shapes surgical decision-making. Discussion highlights include criteria for pancreaticoduodenectomy versus segmental or limited resections, the role of margin status and lymphadenectomy, and evolving data guiding resection strategy for non-ampullary duodenal cancers. Designed for practicing surgical oncologists, this episode emphasizes operative judgment, outcomes data, and the balance between...
info_outlineSurgOnc Today®
In this episode of SurgOnc Today, the SSO HPB disease site working group reviews strategies for implementation of histothripsy ablation in the management of liver primary and secondary malignancies, including a discussion of the evidence supporting it and support from the IDEAL framework for the adoption of surgical innovations into clinical practice. To do so, Drs. Miral Sadaria Grandhi and Zhi Ven Fong, members of the HPB disease site working group, are joined by Drs. Hop Tran Cao, Brock Hewitt, and Jeffrey Barkun.
info_outlineSurgOnc Today®
Drs. Kavita Vakharia, surgical oncologist from City of Hope, Dr Sara Bateni, surgical oncologist at University of Alabama at Birmingham, Dr Nikhil Khushalanai, medical oncologist at the H. Lee Moffitt Cancer Center and James Jakub, surgical oncologist at the Mayo Clinic, Florida, discuss their current practice regarding multidisciplinary management of melanoma with a focus on the role of adjuvant systemic therapy for stages IIB, IIC and IIIA disease.
info_outlineSurgOnc Today®
In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Helen Johnson and Dr. Katrina Mitchell the management of patients with breast cancer diagnosed during pregnancy or lactation, and guidance provided regarding surgery, radiation, and systemic therapy, as reported in the article, "Oncolactation for Patients with Breast Cancer: Executive Summary from the American Society of Breast Surgeons.”
info_outlineSurgOnc Today®
In this episode of SurgOnc Today, Dr. Doreen Agnese, Dr. Anna C Beck and Dr. Andrea Abbott will discuss different delivery models for genetic testing, including traditional genetic testing and point of care testing. We will discuss potential pitfalls associated with point of care testing and interpretation of results.
info_outlineSurgOnc Today®
On this episode of SurgOnc today, Dr. Rosalinda Alvarado and Dr. George Molina moderate a discussion on how to improve the recruitment of Hispanic/Latino patients into clinical trials. Joining the conversation are Jeanette Gonzalez from the University of Illinois Cancer Center and Alas-Wings, Dr. Narjust Florez from Dana-Farber Cancer Institute and Harvard Medical School, and Dr. Kennedy Timothy from MedStar Health and Georgetown University.
info_outlineSurgOnc Today®
On this episode of SurgOnc Today, Mr. Myles Smith, Dr. Hari Deshpande, Dr. Alexandra Istl, & Dr. Danielle Cunningham will discuss the treatment of two rare subtypes of sarcoma, highlighting the differences and challenges of diagnosis and treatment. Both types may represent potentially curable cancers and should always be managed, if possible, by a multidisciplinary tertiary center.
info_outlineIn this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Faina Nakhlis the upgrade rate to ductal carcinoma in situ or invasive cancer following excision for patients diagnosed with flat epithelial atypia on core biopsy, as reported in the article, "Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034).”